What should you know about pt3a melanoma?

T3 describes the measured thickness of the primary melanoma, while a means the pathologist did not identify ulceration. Thickness is a microscope measurement, not an estimate based on how large the spot looks on the surface. The result describes the primary skin tumour only; it does not establish whether regional lymph nodes or distant organs contain melanoma.

Your report may mention margins, mitotic activity, and the biopsy method. These findings help specialists decide whether more tissue should be removed and whether additional staging is useful. Ask for a plain-language explanation of every term that affects your plan.

A specialist will usually consider surgical excision of the biopsy site with a planned margin. The final specimen confirms whether the edges are free of melanoma. With a pT3 primary, sentinel lymph node biopsy is commonly discussed as a way to examine the first draining node pathway, but the decision depends on your circumstances and informed consent.

Take your pathology and operation details to each appointment. Follow wound-care instructions, use shade and protective clothing over healing skin, and begin regular self-checks once the team shows you what to look for.

Seek prompt review for a changing spot, a new pigmented lesion, a growing lump near the scar, or persistent bleeding. After treatment, contact the surgical team about fever, spreading redness, increasing warmth, discharge, wound opening, or pain that is becoming stronger. Emergency assessment is needed for sudden weakness, speech trouble, a seizure, marked confusion, or a severe new headache.

Ask how thickness was measured, whether ulceration and margins were recorded, and what excision is recommended. Discuss the potential value and risks of sentinel lymph node biopsy, whether imaging is indicated, and how follow-up will monitor the scar, remaining skin, and lymph-node areas.